Ptc Therapeutics | search
Click here to view Ptc Therapeutics news from 60+ newspapers.
Bookmark or Share- About PTC Therapeutics - Treatments for Rare DiseasesLearn about PTC Therapeutics, a global biopharmaceutical company. We are fueled by science, and committed to transforming the lives of patients with rare diseases.
- PTC Therapeutics | Pioneers in Rare Disease TreatmentsPTC Therapeutics pioneers pharmaceutical science to transform lives and treat rare diseases, like Duchenne Muscular Dystrophy, Spinal Muscular Atrophy, Huntington's Disease, Leukemia, and more.
- Our Science - PTC TherapeuticsWe have focused our research efforts on two scientific platforms—splicing and ferroptosis and inflammation— where PTC has unique expertise to discover and advance to the clinic innovative therapies.
- PTC Therapeutics - Meet our Leadership TeamThe executive leadership team at PTC Therapeutics is a profoundly inspiring group of innovators working toward a brighter future for rare disease treatments.
- Press Releases - PTC Therapeutics, Inc.WARREN, N.J. , Nov. 27, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that it has entered into an agreement to sell its Rare Pediatric Disease Priority Review Voucher (PRV) for $150 million upon the closing of the transaction.
More
